跳至主要内容
临床试验/CTRI/2025/09/094890
CTRI/2025/09/094890尚未招募不适用

Comparative study between preemptive Ketamine and Dexmedetomidine with intravenous Paracetamol for post-operative analgesia in laparoscopic gynecological cancer surgeries: A Double-blinded randomized controlled trial.

Shubham Kumar1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
To compare the efficacy and safety of pre-emptive ketamine with Intravenous Paracetamol vs pre-emptive dexmedetomidine with Intravenous paracetamol for postoperative analgesia in patients undergoing laparoscopic gynaecological cancer surgeries.

研究概览

简要总结

This is a prospective, randomized, double-blind controlled trial designed to compare the efficacy and safety of preemptive intravenous ketamine with paracetamol versus intravenous dexmedetomedine with paracetamol for post- operative analgesia in female patients undergoing elective laparoscopic gynaecological cancer surgeries. The study will asses postoperative pain scores, total  analgesia consumption and adverse effects associated with each intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
Female

入选标准

  • Female age 18-80 years.
  • Patients of ASA physical status 1,2 &
  • Female Undergoing elective laparoscopic gynecological cancer surgeries.

排除标准

  • Patient’s refusal to participate.
  • Patients of psychiatric disorders and unable to understand VAS and substance abuse.
  • Drug allergy.
  • Pregnant females.
  • History of any underlying cardiac, hepatic, renal dysfunction.

结局指标

主要结局

To compare the efficacy and safety of pre-emptive ketamine with Intravenous Paracetamol vs pre-emptive dexmedetomidine with Intravenous paracetamol for postoperative analgesia in patients undergoing laparoscopic gynaecological cancer surgeries.

时间窗: Immediately after extubating, 0hr, 15min, 30min, 45min, 60min, 2hour, 4hour, 8hour,12 hour, 24hour

次要结局

  • 1. To compare the hemodynamic stability between two groups.

研究者

发起方
Shubham Kumar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Shubham Kumar

Indira Gandhi Institute of Medical Sciences, Patna

研究点 (1)

Loading locations...

相似试验